These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 24686410)

  • 1. Rhythm as a coordinating device: entrainment with disordered speech.
    Borrie SA; Liss JM
    J Speech Lang Hear Res; 2014 Jun; 57(3):815-24. PubMed ID: 24686410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sync Pending: Characterizing Conversational Entrainment in Dysarthria Using a Multidimensional, Clinically Informed Approach.
    Borrie SA; Barrett TS; Liss JM; Berisha V
    J Speech Lang Hear Res; 2020 Jan; 63(1):83-94. PubMed ID: 31855608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Speech treatment for Hebrew-speaking adolescents and young adults with developmental dysarthria: A comparison of mSIT and Beatalk.
    Carl M; Levy ES; Icht M
    Int J Lang Commun Disord; 2022 May; 57(3):660-679. PubMed ID: 35363414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acoustic variation during passage reading for speakers with dysarthria and healthy controls.
    Kuo C; Tjaden K
    J Commun Disord; 2016; 62():30-44. PubMed ID: 27219893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Communication efficiency of dysarthric speakers as measured by sentence intelligibility and speaking rate.
    Yorkston KM; Beukelman DR
    J Speech Hear Disord; 1981 Aug; 46(3):296-301. PubMed ID: 7278175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disordered speech disrupts conversational entrainment: a study of acoustic-prosodic entrainment and communicative success in populations with communication challenges.
    Borrie SA; Lubold N; Pon-Barry H
    Front Psychol; 2015; 6():1187. PubMed ID: 26321996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting Intelligibility Gains in Individuals With Dysarthria From Baseline Speech Features.
    Fletcher AR; McAuliffe MJ; Lansford KL; Sinex DG; Liss JM
    J Speech Lang Hear Res; 2017 Nov; 60(11):3043-3057. PubMed ID: 29075753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Separate and Combined Influence of Cognitive Impairment and Dysarthria on Functional Communication in Multiple Sclerosis.
    Feenaughty L; Tjaden K; Weinstock-Guttman B; Benedict RHB
    Am J Speech Lang Pathol; 2018 Aug; 27(3):1051-1065. PubMed ID: 30054632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of laryngeal dysfunctions of dysarthric speakers.
    Surabhi V; Vijayalakshmi P; Steffina L; Jayanthan RV
    Annu Int Conf IEEE Eng Med Biol Soc; 2009; 2009():2608-11. PubMed ID: 19965223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of clear, loud, and slow speech on scaled intelligibility and speech severity in Parkinson's disease and multiple sclerosis.
    Tjaden K; Sussman JE; Wilding GE
    J Speech Lang Hear Res; 2014 Jun; 57(3):779-92. PubMed ID: 24687042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hybridizing conversational and clear speech to investigate the source of increased intelligibility in speakers with Parkinson's disease.
    Tjaden K; Kain A; Lam J
    J Speech Lang Hear Res; 2014 Aug; 57(4):1191-205. PubMed ID: 24686409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Effects of Intensive Speech Treatment on Conversational Intelligibility in Spanish Speakers With Parkinson's Disease.
    Moya-Galé G; Goudarzi A; Bayés À; McAuliffe M; Bulté B; Levy ES
    Am J Speech Lang Pathol; 2018 Feb; 27(1):154-165. PubMed ID: 29351354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Shorter Sentence Length Maximizes Intelligibility and Speech Motor Performance in Persons With Dysarthria Due to Amyotrophic Lateral Sclerosis.
    Allison KM; Yunusova Y; Green JR
    Am J Speech Lang Pathol; 2019 Feb; 28(1):96-107. PubMed ID: 31072158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Cross-Language Study of Acoustic Predictors of Speech Intelligibility in Individuals With Parkinson's Disease.
    Kim Y; Choi Y
    J Speech Lang Hear Res; 2017 Sep; 60(9):2506-2518. PubMed ID: 28821018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toward phonetic intelligibility testing in dysarthria.
    Kent RD; Weismer G; Kent JF; Rosenbek JC
    J Speech Hear Disord; 1989 Nov; 54(4):482-99. PubMed ID: 2811329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic effects of intensive voice treatment (LSVT LOUD
    Boliek CA; Fox CM
    Int J Speech Lang Pathol; 2017 Dec; 19(6):601-615. PubMed ID: 27705010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring the Acoustic Perceptual Relationship of Speech in Parkinson's Disease.
    Chiu YF; Neel A; Loux T
    J Speech Lang Hear Res; 2021 May; 64(5):1560-1570. PubMed ID: 33900806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of rate control on the intelligibility and naturalness of dysarthric speech.
    Yorkston KM; Hammen VL; Beukelman DR; Traynor CD
    J Speech Hear Disord; 1990 Aug; 55(3):550-60. PubMed ID: 2381196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intelligibility of dysarthric speech: perceptions of speakers and listeners.
    Walshe M; Miller N; Leahy M; Murray A
    Int J Lang Commun Disord; 2008; 43(6):633-48. PubMed ID: 18608608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intonation and speech rate in dysarthric speech.
    Le Dorze G; Ouellet L; Ryalls J
    J Commun Disord; 1994 Mar; 27(1):1-18. PubMed ID: 8006203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.